Barclays’s BlackRock Health Sciences Trust BME Stock Holding History

Barclays’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-31	Closed	-$1K	–	4887
2020 Q3	$1K	Buy	+31	New	+$1.33K	﹤0.01%	5139

Other funds holding BME

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AIP

Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

NRI

NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Barclays's BME Position: Q4 2020 in Review

Barclays sold out of BlackRock Health Sciences Trust (BME) in Q4 2020, closing a stake of 31 shares — an estimated $1K sold.

Barclays first reported a position in BME in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 53 funds tracked by Wall St. Rank hold BME as of Q4 2020.

Barclays reported no remaining BlackRock Health Sciences Trust position as of Q4 2020 after selling out during the quarter.
Barclays sold 31 BlackRock Health Sciences Trust shares in Q4 2020, an estimated $1K.
Barclays first reported a position in BlackRock Health Sciences Trust in Q3 2020 and held it in 1 quarter.
Barclays's BlackRock Health Sciences Trust position peaked at $1K in Q3 2020.
53 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2020.

Based on Barclays's 13F filing for Q4 2020, filed 11 Feb 2021.